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Drawing on a study of members of the UK’s Agriculture and Biotechnology Commission, this paper 
explores the use of Critical Systems Heuristics (CSH) as a structured approach to the inclusion of 
ethics and values in complex policy decisions. 
 
CSH was devised by Ulrich in a planning context, as a way of making explicit the value assumptions 
underlying practical judgements by means of critical reflection. It is rooted in Critical Systems 
Thinking, which challenged earlier notions of systems thinking by introducing a more socially aware 
and critical form of systems practice. 
 
Ulrich used the concept of system boundaries to provide a conceptual framework for dealing with the 
facts and values that underlie a decision. The CSH framework encourages people to consider critically 
such matters as what counts as an ethically-defendable ‘improvement’, who should benefit, and what 
should count as relevant knowledge and sources of expertise. 
 
This paper highlights some of the advantages and disadvantages of CSH as a tool for achieving a more 




Policy decisions surrounding the commercialisation of GM crops are complex and controversial. 
Although the European Commission has granted approval for several types of GM crops to be grown 
commercially throughout the European Union, there are objections from some member states, 
opposition from many NGOs and concern and resistance among the general public. 
 
In the UK, Government has responded to opposition and concern with three main initiatives. It has 
funded large-scale farmer-managed trials of approved GM crops. It has agreed with industry a phased 
introduction or ‘managed development’ of commercial crops. It has extended the range of expertise 
included in its advisory body ACRE (Advisory Committee on Releases to the Environment) and has 
established a new body, the AEBC (Agriculture and Environment Biotechnology Commission), to 
advise it on the more strategic issues and issues of concern to the public. More recently (July 2002), in 
response to AEBC’s advice, it has initiated a public dialogue, involving three supposedly interactive 
strands: a formal public debate, a science review and an economics study. 
 
Although the UK Government’s initiatives go some way towards addressing the concerns that have 
been expressed by various groups and individuals, there are still criticisms that they do not go not far 
enough. In particular, some researchers have pointed out that the general public’s concerns are as much 
about the process of decision-making, and about the value and social assumptions involved, as about 
specific risks of biotechnology and its applications. For example, Grove-White et al (1997) found that 
people felt a sense of being ‘left in the dark’, but that what they wanted was not technical information 
but information that ‘convinces me genuinely that I can trust the judgement and vision of the people 
and procedures governing decisions taken on my behalf’.  
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Similar findings were reported in an EU study, which urged the need for a debate about the purposes 
and social visions driving and shaping research and innovation, as part of an accountable decision-
making process. (PABE) 
 
Other criticisms of the GM decision-making process are that: 
• It draws a narrow boundary round the issues considered to be relevant 
• It is not sufficiently inclusive – participation is limited 
• It is not self-critical and reflexive 
• It deals separately with scientific and ethical issues, and has no clear process for integrating them 
• The value basis of judgements is taken for granted and not open to scrutiny. 
 
This paper discusses an approach called Critical Systems Heuristics that we believe might help to 
address some of these criticisms of the GM decision making process. Section 2 describes the 
theoretical basis of this approach. Section 3 describes how we used it in a study of the UK’s 
Agriculture and Environment Biotechnology Commission. Section 4 provides a summary of our 
results. Section 5 discusses the strengths and weaknesses of the approach (and our use of it) and 
suggests how it might be developed further. Previous discussions of our tests of this approach can be 
found in Carr and Levidow (2000) and Carr and Oreszczyn (2001). 
 
2 The theoretical basis 
 
Critical Systems Heuristics is a name applied by Ulrich to a set of 12 questions he devised to encourage 
critical thinking about the value judgements that underlie planning decisions (Ulrich, 1993; 1996). The 
questions do this by examining the limits or boundaries of decisions, for example, which groups of 
people and types of information have been considered relevant to the decision and which have been 
considered irrelevant and thus excluded or marginalised. 
 
Ulrich’s purpose was to find a way of counteracting what he described as the monopoly of knowledge 
and power accorded to experts and institutionalised science to the exclusion of ordinary people. 
Although Ulrich talks about planning decisions, he intends the term planning to include other kinds of 
social intervention, including policy decisions. His questions are based on three key ideas. The first is 
that, if the aim of such decisions is to bring about improvement, then since improvement is a subjective 
concept, the decision-makers’ view of improvement should be subjected to challenge to test its worth 
in the light of other viewpoints and other value systems. The second is a related point – that the 
participation of a variety of stakeholders is important because different stakeholders may bring 
different insights to bear on the decision. The third is that the boundaries of the system – the people and 
information considered relevant to the decision – are socially constructed. Different values might lead 
to different people and factors being considered relevant, that is, to a different system boundary.  
 
In thinking through his ideas on ‘boundary critique’, Ulrich drew particularly on the work of 
Churchman (1971, 1979) and Habermaas (1976, 1984). Churchman suggested that in order to justify a 
change as an improvement, it is necessary to reflect on the boundaries of the analysis. He said that to 
allow the most inclusive view of improvement to emerge, as much information as possible should be 
considered. Churchman argued that the boundaries of the analysis or system are not ‘givens’ but are 
socially constructed. He proposed that in order to be sure we are defining improvement adequately, we 
should seek out ‘enemies’ of our ideas and engage in rational argument to see if they  
survive challenge. He called this a ‘dialectical process’. 
 
Ulrich, while agreeing with Churchman’s views on inclusivity in theory, argued that for practical 
reasons limits, or boundaries, have to be set. However, people should be able to justify the boundaries 
they set by means of rational argument. Ulrich turned to Habermas for ideas about the nature of 
rationality. Habermas argued that rationality depends on dialogue. Its basis is open and free questioning 
between human beings. Since Habermas recognised that power can have a distorting effect on 
dialogue, he said that rationality depends on an ‘ideal speech situation’ – a situation where any 
assumption can be subject to critique and all viewpoints can be heard.  
 
As in the case of Churchman’s views on inclusivity, Ulrich considers that Habermas’s ‘ideal speech 
situation’ is unattainable in practice. This led Ulrich to the view that a more practical aim is to combine 
critical inquiry (in which no assumption should be beyond question) with systems thinking (concerning 
the boundaries of the inquiry). He developed the set of questions he called ‘Critical Systems Heuristics’ 
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as guidelines for such a boundary critique. Ulrich considers that boundary critique is essentially an 
ethical process, since debates about who and what should be included inside the boundary of the 
system to be improved (as well as the understanding of ‘improvement’) depend on value judgements. 
 
Ulrich’s checklist of questions to guide boundary critique are summarised in Table 1. In devising the 
questions, Ulrich focussed on people and their social roles in the decision process, since it is people 
who determine what constitutes an improvement. He grouped the questions around four social roles, 
three of them concerning the people involved in the decision process and the fourth concerning people 
who are affected but not involved. Among those involved he included the clients (those who are the 
intended beneficiaries of the improvement), the decision-takers (those who have the say), and the 
planners (or experts, those who have the relevant know-how). He named the fourth social role the 
witnesses (those who act on behalf of the affected who bear the costs and/or side-effects). 
 
For each social role, the first question is about who occupies (or should occupy) that role. The second 
question is about a key concern relating to that role and its contribution to the understanding of what 
counts as an improvement. So for the client (or beneficiary) role, the question is about the purpose of 
the improvement (how will the client benefit). For the decision-taker’s role, the question is about what 
resources are under the decision-taker’s control (how much control does the decision maker have over 
the resources needed to achieve the improvement). For the planner (or expert) role, the question is 
about what type of expertise and knowledge is relevant. For the witness role, the question is about the 
provisions made to protect or compensate the affected. 
 
For each social role, there is a third question that draws attention to issues that can arise if there is 
conflict with other social actors about the key concern associated with that role. Ulrich says that the 
way such conflicts are handled contributes to the understanding of what is meant by ‘improvement’. 
For the client role, this third question asks what is (or should be) the measure of improvement. For the 
decision-taker role, the question is about the resources beyond the decision taker’s control. For the 
planner or expert role, the question is about the guarantee that the improvement will work out as the 
planner or expert intend. For the witness role, the question is about how the improvement takes into 
account differences in worldview, or different visions of ‘improvement’. 
 
3 Our approach 
 
To test the relevance of the CSH framework to biotechnology, we used it as the basis of interviews 
with the members of the UK’s Agriculture and Environment Biotechnology Commission (AEBC). The 
AEBC was established in June 2000 by the UK government in response to the crisis in public 
confidence over GM issues (ENDS Report, 2000). Its 20 members include both opponents and 
proponents of GM technology, as well as some who have not previously engaged with the issues. Its 
remit includes offering strategic advice to the government on biotechnology issues, keeping under 
review developments in biotechnology, and advising government on their ethical and social 
implications and public acceptability (AEBC, 2001: 10). As part of this process, the AEBC seeks to 
involve and consult stakeholders and the public on a regular basis. 
 
We chose the AEBC as a clearly defined group of people, with well-informed views, who had been 
selected by government to cover a wide spread of expertise and opinions on GM issues. The 
membership includes scientists, farmers, public interest groups, lawyers and philosophers, as listed in 
Table 2. Only three members declined our request for an interview. We interviewed each member 
individually (and the government official who acts as the AEBC secretary), asking the checklist of 12 
CSH questions. For each pair of questions we asked the ‘ought’ question before the ‘is’ question. We 
did this intuitively at first, but then more deliberately as we realised that the ‘ought’ questions were 
more open, encouraging people to reflect carefully on their own views, whereas the ‘is’ questions 
prompted a more restricted answer. Whenever there was time, we asked for feedback on the questions 





Although people sometimes had difficulty with the way the questions were worded, they had no 
problem in relating them to the topic of biotechnology even though the questions were originally 
devised for a different context. Sometimes people asked for the question to be repeated or asked for 
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clarification. Scientists were less familiar than other people with some of the language. The main 
difficulty was that some people were uncomfortable in responding to the questions without a specific 
pre-defined context or ‘system’. We tried to resist the temptation to provide prompts, because we 
wanted people to answer in terms of a system that was relevant to them. We encouraged people to 
respond in terms of the aspects of biotechnology with which they were most familiar. People mainly 
answered in relation to biotechnology in general, or gm crops. Two answered the questions in relation 
to the AEBC, one in relation to the biotechnology decision-making process, one in relation to the 
regulatory framework and one in relation to risk assessment.  
 
A summary of the answers to each question is provided below. The summaries don’t do justice to the 
richness of the answers and the thought that went into them. There were often long pauses as people 
tried to clarify and articulate their views. 
 
The client/beneficiary role (Qs 1-3) 
 
Q1a) Who ought to be the client or beneficiary? There was considerable agreement over the question 
of who ought to be the client or beneficiary. Most answers drew a wide boundary, referring to the 
consumer, the community at large, citizens, society, the general public. Even the most narrowly defined 
answer – the applicant for consent – was mentioned in the context of the application’s value to society. 
One or two answers drew a very wide boundary, by including the global population, future generations, 
the agricultural/environmental relationship, and nature generally.  
 
Q1b) Who is the client or beneficiary? In answer to the question ‘who is the client or beneficiary’, most 
people recognised that a much narrower boundary existed in practice. The beneficiaries were seen (or 
perceived by the public to be seen) as the developers, biotechnology companies and their shareholders, 
and the research community. One or two people also mentioned farmers. Some pointed out that it was a 
young industry, and that the situation was a dynamic and changing one.  One or two mentioned that the 
public were not being served, that they felt out of control. 
 
Q2a) What ought to be the purpose? No clear view emerged of the purpose. A scientist said ‘I’m not 
sure that there is any ought in this at all’, except that  ‘…the ought is that we should allow progress to 
occur’ since technology can be used for important and benign ends. One member said ‘I don’t think 
anyone really knows what the purpose of all these crops are’ and suggested part of the reason for 
establishing the AEBC was to give people a chance to establish  ‘a more strategic wide-ranging view of 
where we might all be going – a sort of collective drawing of breath’. One answer concerned 
biotechnology’s contribution to plant breeding. Several answers were linked to improving the 
sustainability of agriculture and reducing its environmental impact. Two people mentioned helping less 
developed countries. One person mentioned ‘for the greater good of society’ and another ‘products to 
help meet people’s needs better’. 
 
Q2b) What is the purpose? Again, no clear sense of the purpose emerged. One reason given for this 
was that GM crops are not yet being grown commercially in the UK. Another reason given was that the 
regulatory framework operates on the basis that GM crops will be developed unless there’s a risk, so 
there’s no requirement to consider the purpose or benefits. Several people mentioned economic 
motives – for shareholders, companies, the economy in general.  Two or three people referred to 
motives relating to industry: the consolidation of biotechnology companies with pesticide companies, 
increasing market share, allowing the agricultural industry to gain more control over all the players in 
the field, and (in relation to the decision making system) to facilitate industry’s progress. One specific 
purpose mentioned in relation to GM crops was the more precise targeting of pests. In relation to the 
AEBC, one purpose mentioned was that of bringing the two conflicting sides in the debate together. In 
relation to GM risk assessment, one person mentioned the prevention of harm to the environment, but 
considered that harm was inadequately defined. Another mentioned that the purpose of risk assessment 
to protect health and environment neglects the way that people feel about GM technology. 
 
Q3a) What ought to be the measure of performance? (That is to say, how should we judge the extent to 
which the purpose has been achieved?) This was generally seen as a complex and challenging question, 
with several people mentioning that there would need to be a range of criteria or indicators and that 
these would vary for different stakeholders and perspectives. Examples included: for farmers – higher 
yields, for companies – profits, for consumers – cheap food and intangibles such as feeling good about 
the food. Other indicators suggested were: the position of the UK in the global biotechnology market, 
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the number of individuals benefitting, the acceptance of products, the more efficient use of resources 
especially non-renewables. More general suggestions concerned the efficiency, sustainability, quality 
and environmental impact of food production and measures relating to the quality of life and the 
benefit to society. Two people said the measure should be that the benefits should outweigh any 
negative consequences. Talking specifically about biotechnology in relation to less developed 
countries, one person said the measure should be substantial improvements to the lot of the world’s 
poor. Two measures were suggested specifically in relation to the purposes of the AEBC, one involving 
the monitoring of public knowledge about GM, the other based on the provision of clear statements to 
Government as an outcome of the AEBC’s deliberations. Two people mentioned that it was difficult to 
specify measures because of gaps in our knowledge about possible consequences. One person 
suggested that a way forward was first to agree a generally desirable direction for change, then to 
monitor progress towards that change compared with conventional practice. 
 
Q3b) What is the measure of performance? The main measure of performance at present was seen by 
several people as profitability, relevant mainly to companies, shareholders, growers and retailers. One 
person commented that people were led to believe this was the only measure by inaccurate reporting in 
the media. The only other existing measures mentioned were the position of the UK in the global 
biotechnology market, and physical impacts on the environment and health, although one person 
mentioned that the concept of ‘safety’ being used for this measure of environmental and health impacts 
was controversial. One person pointed out that the reason there is no measure is that GM crops are not 
yet being grown in the UK but that in the US the measures are ease of weed control, profitability, price, 
reduced environmental impact, reduced spraying and novel products. Most answers referred to the lack 
of existing measures of performance and to the difficulties of devising acceptable measures. People on 
the regulatory committees are striving to find answers to such questions for this new technology but as 
one person commented ‘there is a long way to go’. 
 
The decision-maker role (Qs 4-6) 
 
Q4a) Who ought to be the decision maker? Most people were clear that the elected government ought 
to be the decision maker, to balance societal and individual interests and to be accountable for the 
decision. In expanding on this answer, people described the type of on-going democratic consultation 
process they thought was needed to inform government’s decision. For example, people thought that 
government should be aware of the full range of dimensions of concern, it should be advised by 
informed policy makers, experts and non-experts with access to proper advice, it should consult with 
society and listen to the public, there should be a good network to sample opinions, and the decision 
making process should be open and transparent and demonstrate how all the different interests have 
been taken into account. One person pointed out that there are several layers of decision making 
involved and that ultimately farmers should decide, within the parameters set by regulators. Other 
decision makers mentioned were: the statutory authorities (for decisions about whether a particular 
product is safe), individual people making individual choices, industry advised by the AEBC, and 
representatives of citizens approved by society at large and qualified to make ‘sensible’ decisions. One 
person specifically mentioned that lawyers and environmental courts were not appropriate for this type 
of decision. In many respects, the answers reflected aspects of the AEBC’s role in advising 
government, although only two people explicitly referred to the AEBC.  
 
Q4b) Who is the decision maker? Many people thought that in this case the ‘is’ is close to the ‘ought’ – 
that government is the decision maker and is making progress towards establishing a more consultative 
and participatory decision process, for example by setting up the AEBC. More cynical views were that, 
at least in the past, decisions occurred by default and the government was simply ‘rubber stamping’ 
decisions made by others, such as its expert advisers on ACRE. Several groups were mentioned as 
having undue influence on GM decisions: supermarkets, industry, local protesters and pressure groups 
such as the Soil Association (which promotes organic agriculture), multinational corporations (in 
relation to decisions about the development of the technology). As one person pointed out, a distinction 
needs to be made between official decisions and unofficial decisions that can have a significant impact. 
At a more overarching level, the CAP was mentioned as a major influence on agriculture’s direction 
because it forces farmers to farm in the most profitable way possible. One person pointed out that at 
present no-one is free to take decisions – farmers can’t choose because there is a moratorium on the 
commercialisation of GM crops, consumers can’t choose because some supermarkets refuse to stock 
GM products, and the regulatory authorities can’t take decisions because the politicians won’t let them. 
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Q5a) What conditions for successful implementation should be under the decision-maker’s control? 
Q5b) What conditions are under the decision-maker’s control? Q6a) What conditions should be 
outside the decision maker’s control? Q6b) What conditions are outside the decision-maker’s control? 
Some people had difficulty in understanding the meaning of this group of questions, at least in relation 
to biotechnology. Others did not always make a clear distinction between the four parts. Part of the 
problem was that the decision making is still at an early stage and GM crops are not yet being grown 
commercially. As one person said ‘we’re not far enough down the line yet to address this question’. 
Another commented that at present we have a very restricted view of the relevant knowledge, implying 
that we can’t yet say which aspects the decision-maker should or should not control. In addition, there 
are several levels at which the question needs to be addressed. At the national level, the prevalent view 
was that the decision maker should control the aspects relating to health and environmental safety (one 
person expressed this as ‘common environmental/public goods’). Some people also thought the 
decision maker should have control over ethical components of the decision such as ensuring social 
benefits, welfare, rights, justice and the acceptability of the processes of production. One person said 
that all the conditions that society feels strongly about should be under the decision makers’ control. 
The general view was that health and environmental safety are at least notionally under the decision 
makers control, although some people mentioned there are gaps or that the regulatory system is not yet 
adequately rigorous on the environmental aspects. The question of control of the ethical aspects was 
seen as more difficult and as one reason why the AEBC was set up. 
 
On the question of what conditions should lie outside the decision maker’s control, several people 
thought that (subject to meeting regulatory conditions) researchers and developers should be free to 
choose what types of research to pursue, and farmers should be free to make day-to-day management 
decisions. Consumers should be free to choose which products to consume. Government should not 
control these decisions although it might exert an influence, by setting out its vision, laying down 
general principles, offering incentives and using its own purchasing power (for example, selecting 
GM/non-GM products for the health service). Aspects mentioned as currently beyond the decision 
maker’s control (sometimes with the implication of being out of control) were: industry developments, 
social dynamics, public acceptability and commercial adoption.  
 
One or two people specifically mentioned the international level of control or lack of control. For 
example, in some cases international control (for example from WTO) may affect national decision 
makers. Conversely, there is a lack of international control over developments that may adversely 
affect the economies of developing countries (such as GM substitutes for their crop exports). In relation 
to the local control measures that would be needed if a decision was taken to go ahead with GM crops, 
one person mentioned that once the decision maker has put the necessary controls in place, the 
monitoring to check compliance should be independent. 
 
The expert  role (Qs 7-9) 
Q7a) Who ought to be involved in the research and development of the system? [For science-related 
issues, such as GM, this question is ambiguous since it can be understood in a strict physical sense, as 
R&D of a technology, or in a more general and abstract (systemic) sense as the design of the system.] 
People addressed this question at different levels. Several people referred to an overarching level to do 
with the need for a good process to inform the direction of agriculture and provide a framework for 
biotechnology research. They thought this process should involve finding out society’s needs, to target 
products for which there is a demand, so it should include a broad range of people, a cross-section of 
the community, as well as drawing on experts such as scientists. There was one view that the scientists 
involved should include those with an industry background and a contrasting view that they should be 
independent. Environmental scientists and ecologists were specifically mentioned, as were 
sociologists/social scientists. One person mentioned the need for new forms of expertise and social 
intelligence, to help understand such matters as science’s limits, tacit social questions, human dynamics 
and how people reach judgements, and to help overcome mechanistic and complacent thinking. At the 
level of biotechnology research and development, there were several comments about the need for the 
public sector to play a bigger role, to address the existing imbalance between private and public sector 
research. Comments about this public sector role included: that a broad range of publicly funded 
institutions should be involved not just big industrial companies, that public research funding should be 
used for the public good, that the government should encourage health and safety research and the 
training of researchers, that research findings should be freely available and that applied research 
should not just be left to industry. One person mentioned that industry’s expertise and role was in 
researching profitable products. There was a view that not just the private sector but also the public 
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sector should consult widely with stakeholders, including NGOs and the public, at an early stage of 
research and development. Two people referred to the kind of expertise needed at the stage of 
implementation or technology transfer: one said this should be independent of government once a 
tough regulatory framework was in place; the other thought there was a need for a cross-cutting body to 
oversee implementation. 
 
Q7b) Who is involved in R&D? As with Q7a, the answers related to several different systems, for 
example the scientific research system, the policy decision-making system (including the AEBC), and 
the risk assessment system. In relation to the scientific research system, several people mentioned that 
it is too dominated by big companies. Even in the public sector, government research council funding 
is being replaced by industry funding. One person said that it was wrong to separate basic research 
from applied research, with basic research being done mainly by the public sector and applied research 
by the private sector. Another said that the private sector should take on more of the burden of basic 
research. There was a view that the research should be done by independent scientists, rather than 
funded by groups with particular interests. In relation to the policy decision-making system, several 
people thought that although efforts were being made to be more inclusive there was still a long way to 
go. Although people accept that scientific expertise and people with expert knowledge have to be 
involved at the core of the decisions, the current disciplinary base involved, for example in risk 
assessment, was seen as still relatively narrow. Decision making was seen as still ‘expert-driven’, 
mechanistic and operating in a ‘culture of complacency’ even though it was acknowledged that some 
new thinking is going on. One person said the scientists who’ve been involved with the technology for 
a long time have become sanguine about it, and have lost the ability to see it as members of the public 
do ‘with fresh eyes’. It was acknowledged that huge efforts have been made over the last two to three 
years to find ways of involving the ‘silent minority’, but the efforts have been patchy – local people 
and farmers need to be involved and ways have to be found to take account of changing views. There is 
little sign yet of an appreciation of public opinion or of ways to describe it so that it can be taken into 
account in decisions. In contrast to these mostly critical views, two people thought the system was 
operating as it should, involving all those who should be involved, at least to some degree. 
 
Q8a) What sort of expertise should be involved and how? There was some overlap between the 
answers to this question (concerning the type of expertise or knowledge involved) and the answers to 
question 7 (concerning the people involved). Types of expertise mentioned specifically were: scientists 
(molecular geneticists, physiologists, agronomists), environmentalists, economists, technologists, 
ethicists, sociologists, the practical expertise of farmers, consumers, NGOs, political expertise, and 
product and efficiency expertise. Although scientific expertise was seen as central, only one person 
restricted their answer to scientific expertise, and they mentioned the need to involve the whole range 
of science and to find out more about the impacts of GM crops, for example on soil and bees. One 
scientist was wary of involving sociologists. Most people thought a wide range of expertise needed to 
be involved, with several answers referring to a system with two components or stages, one involving 
scientific or technical expertise and the other a broader expertise to set the technology in its social 
context, reflect on society’s concerns, subject the science to common-sense questioning, establish the 
overall strategic direction – much like the AEBC’s role in relation to ACRE. One person thought that 
the social context should be considered before the research (with more attention given to research into 
urgent issues rather than the ‘whims’ of scientists), another that the social context (e.g. acceptability 
and safety) should be considered after efficient products had been developed, and a third saw the need 
for context setting both before and after product development (before to consider strategic direction 
and after to consider technology implementation). Two people thought that the term ‘expertise’ was 
restrictive and spoke of the need to widen what counts as relevant knowledge. As one said, ‘although 
you have ethical experts, if you have ethical concerns you are not always an ethical expert … the very 
fact that they are concerns means they have to be dealt with …’, that is, people with ethical concerns 
are not always experts but their concerns should be considered as relevant. How to involve the public 
and take account of nebulous concerns was seen as problematic. One person referred to the AEBC as 
providing the opportunity for people ‘to let off steam’. Specifically in relation to risk assessment, one 
person mentioned the need for expertise concerning the cumulative, long-term and indirect effects. 
 
Q8b) What sort of expertise is involved and how? As for Q8a, people perceived an overlap between the 
answers to this question and those to Q7, so in some cases they didn’t answer it separately. There was a 
general view that the expertise involved is narrower than it should be, too much technology-led, and 
more pure science-based than desirable. Several people commented that this situation is changing and 
moving in the right direction, for example in the case of risk assessment the expertise involved is 
 7
EURSAFE4-CSH-paper.doc 18 March, 2003 
widening, and lay knowledge is being considered although as yet there is no clear framework that 
allows it to be taken into account. Several people referred to the AEBC’s role, for example in 
discovering the gaps in expertise that need filling. They also referred to the AEBC’s struggle to find 
fair and meaningful ways of involving a wider range of views, particularly among the public. In 
discussing this struggle, one person mentioned the need to address the tendency for ‘fanatics on both 
sides’ to dominate debate and the question of the extent to which environmental groups can be said to 
represent their members’ views.  
 
Q9a) Who or what should be assumed to be the guarantor or guarantee that the system will work? 
Liability is one of the six topics that the AEBC have chosen to focus on, so most members had already 
thought about this question. Most people thought that responsibility should lie either with the producers 
of GM technology or with government or with both. There was a view that those who produce and sell 
should be responsible for their products and should withdraw them if they are no good, as with any 
conventional products. While one person said that industry recognised this responsibility, another 
feared that seed companies would not accept responsibility. Ministers and government were seen as 
responsible because they make the decisions; they are responsible for providing a safe environment and 
dealing with any problems. It was recognised that there is no such thing as zero risk, that there is 
always a level of uncertainty and that it is difficult to foresee the future, so government has to provide a 
form of insurance and step in if the system breaks down. The need for independent monitoring was 
mentioned, to provide an early warning system and an opportunity to stop if things go wrong. Two 
people mentioned the idea of an environmental contingency fund, financed by a levy on beneficiaries 
(companies, farmers and, to a small extent, consumers) to spread societal risks and compensate for 
unforeseeable damage. It was a concern that at present there is no room for financial redress – there 
needs to be clear liability. However, two people noted that recourse to the legal system would not be an 
appropriate remedy since it would be difficult to assign blame on an individual and take them to court. 
Another person mentioned that responsibility would depend on what went wrong; for example, it might 
be the policy framework, or a product, but the negative response of consumers implies that it is the 
process that is wrong. One difficulty in assigning responsibility is the problem of defining what counts 
as ‘harm’. One person suggested a need for an independent regulator (as exists in the UK for example 
for water supply), who could be called on to arbitrate. One person commented that the UK has to work 
within a framework [on liability] set by the EU. Specifically in relation to the AEBC, one person said 
there could be no guarantee the AEBC would work; it was a ground-breaking experiment. 
 
Q9b) Who is the guarantor or guarantee? Nearly everyone said that there in no explicit guarantor or 
guarantee at the moment. There are bits of law that are relevant, for example, the customer has a legal 
right to compensation if a product doesn’t perform as claimed, and a person might claim redress from a 
company if a product affected their health, but it’s not clear who is responsible in the case of 
environmental harm or long-term consequences. Three people said that one could argue, or people 
assume, that the guarantor is government and industry. One person suggested that once there is a 
licensing system, the licence-holder will be the guarantor. 
 
The ‘witness’ role (Qs10-12) 
Q10a) Who should represent ‘the affected’ (for example, future generations, wildlife?) Several people 
thought that everyone should be involved in ensuring ‘the affected’ are represented. A democratically 
elected government has a responsibility to steer society in a way that represents everyone, including 
future generations. Government has to make sure a rigorous regulatory system is in place, with critical 
evaluation of experts by experts on the long-term issues. One person commented that there should be 
no need for representation since the interests of the affected should be automatically built into the 
regulatory system.  Several people mentioned a role for groups representing different interests, 
although one qualified this by adding that those involved should be responsible enlightened groups 
(such as the Consumers Association and the National Farmers Union). One person mentioned that 
NGOs should act as a ‘backstop’, whilst another said that reliance on NGOs to provide this role has to 
change. Three people mentioned the need for overarching strategic bodies to advise government, to 
synthesise the views of different groups and the public and represent the affected. Two of these 
specifically mentioned the AEBC as attempting to fill this role to the best of their ability. However, two 
people mentioned that ways still have to be found to ensure that existing approaches to harnessing 
‘unheard voices’, ‘public sensibilities’, and philosophical and ethical questions become a formal part of 
the decision making process, so that decisions ‘go with the grain’ of public opinion. Three people 
mentioned the problem of ephemeral companies and government ministers in relation to taking account 
of the long-term view. One person commented that government’s role in representing ‘the affected’ is 
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diluted by the effects of globalisation. One person challenged the assumption implicit in the question, 
that there will be negative effects, saying that companies are conscientious about not causing harm.  
 
Q10b) Who does represent ‘the affected’? About eight people said that in practice NGOs had taken on 
this role, but the attempts by NGOs to get other voices heard and act as ‘guardians of the social 
context’ was not necessarily viewed as satisfactory. One favourable comment was that NGOs’ 
arguments help to draw out people’s views and that NGOs have longer memories than companies and 
civil servants. A more critical comment was that some NGOs are more concerned about increasing 
their membership than about representing their members’ views. Some people thought that the ‘is’ is 
close to the ‘ought’, in that government and strategic bodies do try to think of the environment and 
other generations, and that the range of bodies involved ensures a range of perspectives are considered. 
Other, more critical, comments were that no-one in particular is assigned an advocacy role and it is 
unclear who should speak for ‘the affected’, only a proportion of stakeholders have a say, interest 
groups are involved in an ad-hoc way, the representatives are self-appointed, and that evaluation of GM 
crops does not look far enough into the future. One person who commented that independent 
organisations should represent ‘the affected’, thought that the National Consumer Council and the Food 
Standards Agency provided good examples but was less sure about English Nature and the 
Environment Agency. 
 
Q11a) To what extent should ‘the affected’ be given the chance to escape or challenge the promises 
and premises of ‘the involved’? Several people found this question odd or asked for it to be repeated. 
Most expressed in quite strong terms the view that everyone should have the right to challenge (one 
person added, provided they kept within the law and were well-informed) and freedom of choice (for 
example, by the labelling of GM products). There were several remarks about how these rights could 
be handled effectively and responsibly. For example, there are practical difficulties involved in 
labelling, and in ensuring that challenges come from responsible and representative groups. There were 
two related comments about the need for government to make rigorous attempts to gather views and 
the need for people to feel that decision makers understand and consider their concerns, but also 
comments that the government can’t ask every individual, that it has limited capacity to respond to 
consultations, and that many views are not expressed. One person commented that people rarely have 
access to the resources and expertise they need in order to challenge decisions – a way needs to be 
found of balancing the power of the ‘affected’ with that of the ‘involved’. Three people commented 
that opting out (‘the chance to escape’) will not be an option, or will be extremely difficult since, they 
argued, GM contamination affects people’s ability to choose to buy, eat or live near non-GM products 
or crops. One added that this lack of choice makes it all the more important that everyone has the 
opportunity to be involved in GM decisions and that future generations are considered, since the 
implications affect everyone. The need to resolve the tension between organic farmers and farmers who 
grow or would like to grow GM crops was mentioned, as was the need to do further work on separation 
distances required to allow co-existence of GM and non-GM crops and the need to compensate farmers 
whose produce is affected by GM contamination. 
 
Q11b) To what extent are ‘the affected’ given the chance to escape or challenge? People tended to 
make a clear distinction between ‘escape’ and ‘challenge’ and answer in relation either to one or to the 
other; only two people responded to both. On the question of ‘escape’, three people pointed out that 
since there is little commercialisation yet, the question is not yet relevant. Two of those observed that 
the lack of commercialisation meant that farmers and consumers were not free to choose to buy GM. 
Two people mentioned that labelling will allow people to choose to avoid GM in future. Two people 
said that escape is difficult or impossible – the consequences affect everyone. Three people talked of 
escape in terms of what might happen if adverse impacts occurred: one mentioned that legally if there 
was evidence of harm then commercialisation could be stopped, one mentioned that environmental 
groups are arguing for compensation, and one mentioned that there are real concerns about the question 
of liability in the case of environmental harm. On the question of ‘challenge’, three people thought that 
there are now opportunities at public meetings and that government is becoming more aware of people 
power. However, several others expressed reservations about these opportunities or pointed out the 
difficulties. For example, one said it is easy to say there must be public consultation, implying that in 
practice it’s difficult, a view reinforced by another person who commented that sampling public 
opinion is difficult and that people’s views can depend on their experience that day. One mentioned 
that people’s concerns are not understood within the current decision-making process and are dismissed 
because they don’t fit into the scientific discourse. Another, referring to their previous comment about 
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the need for more balanced access to expertise and resources, said that the imbalance at present is 
enormous, so that a challenge is only possible if a very well-resourced NGO is involved. 
 
Q12a) What worldview should underlie the design of the system? This is a big and open-ended 
question. One person commented ‘Is there a given set from which to choose?’ Nevertheless, most 
people (including this person) had little difficulty answering the question. Many expressed fundamental 
ethical beliefs. For example, the worldview should be inclusive, tolerant, egalitarian and equitable – a 
just society for humans and non-humans; it should consider the long-term, our dependence on 
resources, it should be global, flexible and inclusive; it should be based on equity, fairness and justice, 
with long-term planning; it should accept responsibility for future generations and other inhabitants of 
the planet, it should respect the integrity of species, it should value equal opportunities, it should not 
exacerbate the divide between rich and poor, it should be humble about our ability to see the whole 
picture; it should be a balanced worldview, about providing opportunities for society – health, welfare 
and quality of life – but also about valuing economic strength; it should encourage progress but with 
huge caution. Some answers were less fundamental, in that they referred more specifically to the UK 
context, or to agriculture, food and gm. For example, the worldview should be realistic about the social 
context, about what we do and don’t know, and about what can and can’t be achieved in the context of 
British society; it should be one that accommodates a diverse agriculture and provides a genuine choice 
for society within the practicalities of agriculture; it should be about feeding the world and doing it 
sustainably; it should be one that ensures biotechnology is implemented in such a way as to benefit the 
environment and health worldwide; it should be one that allows each country to have the right to self-
determination and not be forced to accept a technology; it should be a worldview that allows people to 
feel that all the research that could be done has been done before gm is introduced. Three people 
referred to the importance of considering everyone’s worldview rather than allowing a particular 
worldview to dominate, and mentioned how difficult this was to achieve in practice – for example how  
much weight to give to different viewpoints, what can be done about views that aren’t expressed. One 
of these mentioned the tough process of trying to reach some form of accommodation in the AEBC 
among members with diverse worldviews, describing it as ‘sanding down’: ‘I think all of us, 
particularly the scientists, have changed our worldview over the last six months of some very emotional 
times together, and a lot of shouting. So I think you have to somehow build into the design of the system 
a worldview that’s been contributed to by, and almost sanded down by, people with different 
worldviews because I think we’re getting there almost. I’d say we’ve got a more common worldview 
now than ever we thought we would.’ One person took the term ‘worldview’ to mean a single world 
view, answering that there’s no such thing, but adding that there’s a danger of the western view being 
seen as the world view, for example the western  NGOs who presume to speak on behalf of Indian 
farmers. 
 
Q12b) What worldview does underlie the design of the system? The contrast between the idealistic 
answers to the ‘ought’ part of the question and the answers to the ‘is’ part was quite stark. The most 
strongly worded answer was that the worldview is one of ‘rampant unfettered capitalism’. Other people 
made related points, though less forcefully, for example: economic imperatives hold sway; market 
forces; short-term competitiveness based on rapid financial returns; the profit motive. Several made the 
point that the dominance of the economic motive distorts a more balanced view that takes into account 
other values such as health, welfare and quality of life, or at least only pays lip service to it. One person 
mentioned that it is a worldview that is technology driven, rather than benefits driven, and another said 
that scientific claims are dominant. One said the worldview is one that holds that the biological world 
is at our service, to be manipulated for our benefit. Two people said that the worldview is that gm 
technology is a good thing and should go ahead unless there is evidence of harm. Several answers 
referred to the people or groups who hold the dominant worldview. For example, one said that since 
America is the home of gm and the biggest nation in the world, their worldview predominates, which 
plays into the hands of gm opponents because people don’t like being pushed around. A related 
comment was that the worldview is that of the big players, although the opposition has halted the big 
players at present. One person distanced themselves from their answer by referring to it as a public 
perception - the worldview is that of the developers of the products pursuing their own ends, which are 
not in the interests of the consumer. Two people referred to the danger of the western view being 
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The CSH questions prompted people to reflect deeply on their own beliefs and values, in some cases on 
aspects of the gm debate they had not previously considered. People described the questions as 
‘searching’ and ‘thought-provoking’, raising relevant issues. Some people mentioned that they would 
have liked more time to take in the questions or to think them through more carefully, or would have 
liked a ‘crib-sheet’ to remind them of the questions when their chain of thought led them away from 
the main focus. Overall, we conclude that critical systems heuristics is an approach that merits further 
investigation as a practical tool to incorporate ethics and values into complex policy decisions such as 
those surrounding biotechnology. In this section we first make a few general observations about the 




Summarising such detailed answers proved difficult. Summarising the analysis under question 
headings provides some comparison of the diverse viewpoints but loses the links that an individual 
makes between different questions and that provide an indication of their overall values and concerns.  
 
Some of the questions had been considered previously by this group of people, so were answered fairly 
easily, for example the question of the guarantee or guarantor had been discussed by the AEBC in 
terms of liability. Many of the other questions had not been considered previously by most people; they 
often spent some time working their way to an answer in these cases, for example on the purpose of the 
system. 
 
Occasionally the answers to the ‘ought’ and ‘is’ parts of the question were similar, for example for Q4 
on the decision maker. Proponents of biotechnology were more likely to perceive a near 
correspondence between ‘ought’ and ‘is’.  Much more often people acknowledged that there was a 
wide discrepancy between the way they thought things ought to be and the way they perceived them to 
be at present, for example for Q1 on the intended client or beneficiary, although they sometimes 
commented that the situation was changing. 
 
For some questions there was a considerable measure of agreement, for example on Q1a and Q4. 
 
Recurring topics, raised in relation to several questions, included the difficult question of how to 
involve the public in a meaningful way and how to make sure that the views heard are representative 
rather than limited to a vociferous but unrepresentative minority. 
 
Defining ‘the system’ 
 
Other than saying that the questions referred to biotechnology, we deliberately left the definition of ‘the 
system’ vague, so as to allow people to define their own relevant system and its boundaries. Most 
people felt uncomfortable with this initially, and checked at least once, especially during the first two 
questions, what was meant by ‘the system’.  With hindsight, we perhaps should have spent more time 
explaining the basis of the approach – that it views the system as being constructed by an individual’s 
perceptions rather than as an objective entity. One way to do this might be to work out a systems map 
(or maps) with the person being interviewed before starting the questions, basing the map on the 
aspects of biotechnology they consider to be the most relevant and amending, or adding to, the map as 
the questions are answered.  A compromise between leaving the definition of the system up to the 
individual, or providing them with a precise definition, would be to focus on a particular system such 
as the regulatory system while still leaving open the question of that system’s components and 
boundary. This might be the appropriate approach if the CSH set of questions were to be used routinely 
to check values regarding a specific decision at a specific time. 
 
For this test of CSH, we deliberately chose a highly articulate group of people with diverse expertise. 
One way of extending the approach to broader, less knowledgeable and less articulate groups might be 
to use the answers from the articulate group to define diverse relevant systems, then use those as the 
basis for a more focused set of questions, and a selection of answers, with the wider groups. 
 
Language and accessibility 
 
The wording of some of the questions is awkward and unfamiliar, making their meaning difficult to 
understand. For example, people found the wording of Q11 in particular ‘tortured’ and ‘odd’ (To what 
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extent should the ‘affected’ be given a chance to escape or challenge the promises and premises of the 
‘involved’?). One scientist referred to the wording of the questions as ‘sociology speak’: ‘They’re not 
accessible to someone who doesn’t use that kind of, I’m not sure, I guess it’s sort of sociology speak as 
opposed to science speak’. For use with a wider audience it will be particularly important to reword the 




People sometimes answered questions by referring to other people’s views rather than to their own, for 
example, in answer to Q1b (Who is the beneficiary?): ‘The public perception is that the benefits go 
largely to the developers and companies’. In some cases this seemed to be a way of distancing the 
person from a critical view; in other cases it was used to express a widely held view that was contrary 
to the person’s own view. 
 
A somewhat different but related point is that people sometimes wondered which ‘hat’ to wear in 
answering the questions. The type of people who are appointed to committees such as the AEBC tend 
to have more than one occupation or role, for example they may be a farmer, a member of an industry 
body and a local council member. One person commented that he had eight different ‘hats’ and could 
potentially answer the question in a different way for each of them. Sometimes it was clear from the 
answer that a person was speaking with a specific hat on, for example as a lawyer by commenting on 
the legal aspects.  
 
While the issue of ‘hats’ might be important if CSH were being used to map out a particular person’s 
beliefs and values, in general it should not be a problem, since part of the purpose of CSH is to explore 
differences in boundary judgements and each ‘hat’ makes a valid contribution to this purpose. 
 
Overlapping questions or answers 
 
People occasionally commented on an overlap between questions, or in their answers to two related 
questions. For example, one or two people felt that in answering Q1 on the client or beneficiary they 
had also answered Q2 on the purpose – if the client of gm risk assessment is the general public, then 
the purpose is to serve the general public. Other people commented on an overlap in their answers to 
Q7 on the expert (Who ought to be/is involved in research and development?) and Q8 on expertise 
(What sort of expertise should be/is involved?). Quite often the answers to the ‘ought’ and ‘is’ 
questions were mixed together. In part, this is because in working out their answers, people did not 
compartmentalise their thoughts under the separate headings or in the linear sequence of the questions. 
Sometimes their answer to one question prompted further reflections on an earlier question. 
Overlapping answers can make analysis difficult and may be a problem if the purpose of the questions 
is a rigorous comparison of views. However, if the purpose is to encourage critical self-reflection and 
an exploration of values or boundary judgements, then a somewhat flexible approach to the interview 
questions avoids checking the interviewee’s flow of thought. 
 
In the case of Q5 (What conditions for successful implementation should be/are under the decision-
maker’s control?) and Q6 (What conditions should be/are outside the decision-maker’s control?), after 
the first few interviews we always asked these questions together. This was because people had 
difficulty deciding on the scope of Q5, so that asking Q6 at the same time helped to explain this. Even 
so, people did not find this set of questions easy to answer, as already mentioned, partly because 
implementation (in the case of the commercial growing of gm crops) has not yet occurred in the UK.  
 
Two questions in one 
 
Three questions have two parts to them. Q7 asks about research and development; one person 
commented that research tends to be about fundamental science whereas development is about the 
application of science, so the answer for each might be different. (There was a further slight difficulty 
with Q7, in that research and development (R&D) has a precise meaning in the context of science and 
technology, whereas it might have a more general meaning in the context of planning. People 
sometimes answered it in the specific sense and sometimes more generally.) Q8 asks what sort of 
expertise should be involved and how; nearly everyone overlooked the second part of this question. 
Q11 asks about escape or challenge, and promises and premises; some people did try to answer each 
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part of this question separately, though most answered only one part. Restricting each question to one 
part would make the meaning clearer. 
 
None of these criticisms alters our initial view that critical systems heuristics is a potentially useful tool 
for including ethics and values in complex policy decisions such as those associated with 
biotechnology, and that it might help to address some of the current criticisms of the gm decision-
making process. Ulrich suggested that critical systems heuristics can be used in three modes. It can be 
used self-reflectively, encouraging individuals to ask themselves ‘What are my boundary judgements?’. 
It can be used consensually, allowing groups to ask ‘Can we agree on our boundary judgements?’. And 
it can be used conflictually, allowing critics to ask ‘How can we challenge your boundary 
judgements?’. In this test we have used it in the self-reflective mode. From the rich and thoughtful 
answers given to the questions, and the comments made about the searching nature of the questions, it 
is evident that the people interviewed did find that it encouraged self-reflection. It would be useful to 
test it consensually with the same group of people, not necessarily to try and achieve consensus but to 
establish where agreement can and cannot be reached. Comparison of boundary judgements within a 
group setting might encourage further critical self-reflection.  
 
It seems likely that further development will be needed before the use of this tool can be extended to a 
wider, less knowledgeable and less articulate audience. Nevertheless, it seems well worth making the 
effort if the result is a more inclusive process that allows and encourages people to question the values 





AEBC, 2001. Work Plan, January 2001.  
ENDS Report, 2000. New advisory body enters GM “maelstrom”. ENDS Report, June, 38-39. 
Carr, S. and Levidow, L. (2000). Exploring the links between science, risk, uncertainty and ethics in 
regulatory controversies about genetically modified crops. Journal of Agricultural and Environmental 
Ethics 12: 29-39. 
Carr, S. and Oreszczyn, S. (2001). Test of a systemic framework for incorporating ethics and values 
into biotechnology policy decisions. Proceedings of the Third Congress of the European Society for 
Agricultural Food Ethics, Florence October 2001. 
Churchman, C.W. (1971). The Design of Inquiring Systems: Basic Concepts of Systems and 
Organization. New York: Basic Books. 
Churchman, C.W. (1979). The Systems Approach and its Enemies. New York: Basic Books. 
Grove-White, R., Macnaghten, P., Mayer, S. and Wynne, B. (1997) Uncertain World: Genetically 
Modified Organisms, Food and Public Attitudes in Britain. Lancaster, CSEC. 
Habermas, J. (1976). Communication and the Evolution of Society (English edition 1979). London: 
Heinemann. 
Habermas, J. (1984). The Theory of Communicative Action, Volume One Reason and the 
Rationalisation of Society; Volume Two The Critique of Functionalist Reason. Cambridge: Polity 
Press. 
Ulrich, W (1993). Some difficulties of ecological thinking, considered from a critical systems 
perspective: a plea for critical holism. Systems Practice 6: 583-611). 
Ulrich, W. (1996). A Primer to Critical Systems Heuristics for Action Researchers. Hull: Centre for 
Systems Studies, University of Hull. 
 13
EURSAFE4-CSH-paper.doc 18 March, 2003 
 
Table 1 Critical Systems Heuristics checklist of roles and questions 
 
 
The client/beneficiary’s role 
Q1 Who ought to be/is the client or beneficiary of the system? 
Q2 What ought to be/is the purpose? 
Q3 What ought to be/is the measure of performance? 
 
The decision maker’s role 
Q4 Who ought to be/is the decision maker? 
Q5 What conditions for successful implementation should be/are under the decision maker’s control? 
Q6 What conditions should be/are outside the decision maker’s control? 
 
The expert’s role 
Q7 Who ought to be/is involved in the research and development of the system? 
Q8 What sort of expertise ought to be/is involved and how? 
Q9 Who or what should be/is assumed to be the guarantor/guarantee the system will work? 
 
The ‘witness’ role 
Q10 Who should/does represent ‘the affected’? 
Q11 To what extent should/are the ‘the affected’ be given the chance to escape or challenge the 
promises and premises of ‘the involved’? 
Q12 What worldview should/does underlie the design of the system? 
 
   
 
Table 2 Membership of the UK’s Agriculture and Environment Commission 
 
Scientists 
 GM crops and biosafety 
 Molecular biology, medical 
 Ecologist 
 Nature conservation/biodiversity 
 Land use 
Farmers 
 Organic meats, tenant farmer 
 Arable see production 
 Arable (non-food crops) 
Public interest groups/bodies 
 Green Alliance 
 GeneWatch UK 
 National Consumer Council 
Lawyers 
 Land economist/lawyer 
 Barrister (environmental law) 
Philosophers 
 Theologist 
 Applied bioethicist/food ethics council 
Other  
 British Society of Plant Breeders 
 Sociologist (environment and society) 
 Broadcaster and writer (science) 
 Industry consultant 
 Health service layperson 
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